LifeCycle Pharma Moves LCP-Tacro™ into Clinical Phase 3 - Earthtimes (press release) PDF Print

The clinical trial protocol has been reviewed by FDA, and LCP expects to enroll approximately 300 stable kidney transplant patients in the program. ...

read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.